Pharmacies are demanding tougher regulation of the online sale of weight-loss jabs amid a predicted new year’s boom in demand.
The National Pharmacy Association (NPA), who represent independent community pharmacies, urged the regulator to require greater consultation with patients before dispensing weight-loss jabs and other high-risk medication online.
Current rules, the NPA said, “leaves the door open for medicines to be supplied without appropriate patient consultation and access to patient records”.
Nick Kaye, chair of the NPA, said: “Obesity is one of the biggest challenges facing our country and pharmacies want to play their part in helping patients lose and maintain a healthy weight. Weight-loss injections can play an important role in efforts to tackle obesity when prescribed as part of a carefully managed treatment programme for patients who are most in need of support.
“However, we are concerned that the current regulations allow some patients to inappropriately access weight-loss injections without proper consultation or examination of historical medical records.”
The NPA urged regulators to require that pharmacies conduct a full two-way consultation with patients before dispensing “higher-risk” medication such as weight-loss jabs.
The General Pharmaceutical Council has produced draft guidelines on weight-loss medication. But the NPA said the proposed safeguards “still leaves the door open for medicines to be prescribed/supplied without appropriate two-way direct patient consultation and access to patient records for a full clinical picture particularly where high-risk medicines are involved, and the risk to patient safety remains”.
The NPA has called on the regulator to ensure Wegovy and Mounjaro injections are prescribed by online sellers only after a full two-way consultation including the careful consideration of a patient’s medical history, rather than replying on information provided in online questionnaires.
The call comes amid warnings of a boom in demand for weight-loss treatments this year as the government look to expand the rollout of the medication over the next few years. Many pharmacies dispense weight-loss medication or offer injectable medicines as part of private weight-loss programmes.
The NPA has previously urged patients to avoid buying weight-loss injections from unregulated online sellers, who may be selling dangerous fake counterfeit medications. The Medicines and Healthcare products Regulatory Agency also advised patients not to purchase medicines from unregulated suppliers such as beauty salons or via social media.
after newsletter promotion
Some patients who have been wrongly prescribed weight-loss injections include those who have previously had eating disorders or who have not been in the licensed BMI categories and have low BMIs, putting them at greater risk of severe adverse effects.
Kaye said: “There’s nothing wrong with online services in principle, but it’s important the regulator takes this opportunity to make compulsory a full consultation before dispensing high-risk medication such as weight-loss injections and ensure supply is prioritised for those in most clinical need, including those with type 2 diabetes.
“Medicines are not like ordinary goods for sale: they must be handled with great care because they have the power to harm as well as to heal. We urge anyone who is unsure about medicine to speak to their pharmacist for advice.”
